Overview
- WHO published the new adult Type 1 diabetes guidelines, which were released on Saturday, November 14, 2026, and set clinical and policy standards for diagnosis, treatment and monitoring.
- The document recommends intensified insulin therapy when needed, defined as three or more daily injections with dose changes based on blood glucose, food and activity.
- To reduce misdiagnosis of adult Type 1 as Type 2, WHO advises diagnostic testing such as pancreatic autoantibodies and C‑peptide when the diagnosis is uncertain.
- For monitoring, WHO endorses regular self‑testing, continuous glucose monitoring where available, and HbA1c testing up to every three months with a target of 7% or lower for most adults.
- WHO prefers lower‑cost human insulin for broad access while allowing analogues for specific needs, sets a 2030 target for universal affordable insulin and self‑monitoring, and will give countries practical tools to implement the guidance.